22nd Century Group (XXII) 2014年年度报告「NYSE」.pdf

《22nd Century Group (XXII) 2014年年度报告「NYSE」.pdf》由会员分享，可在线阅读，更多相关《22nd Century Group (XXII) 2014年年度报告「NYSE」.pdf（78页珍藏版）》请在三个皮匠报告上搜索。

1、2014 ANNUAL REPORT2014 ANNUAL REPORT22nd Century Group,Inc.9530 Main StreetClarence,New York 14031Telephone:(716)270-1523Fax:(716)877- 22nd Century Group,Inc.22nd Century Group,Inc.2014 ANNUAL REPORTThe material in this presentation is provided for the purpose of giving information about 22nd Centur

2、y Group to investors and is not provided for tobacco product advertising,promotional,or marketing purposes.This material does not constitute and should not be construed as constituting an offer to sell,or a solicitation of an offer to buy,any of our tobacco products.Innovative Cigarettesfor those wh

3、o enjoy smokingGroundbreaking Smoking Cessation Product in Developmentfor those who wish to quitDear Fellow Shareholders:As expected,2014 represented a period of transition for 22nd Century Group.From our inception,the Company focused primarily on research and development.Since the latter part of la

4、st year,however,we recast our priorities to instead concentrate our efforts on monetizing our exceptional intellectual property portfolio.Coinciding with this change,in March 2015,our Board of Directors appointed me Chief Executive Officer.I am honored and tremendously excited to have been chosen to

5、 lead the Company at this momentous time in our history.Our technology is extraordinary.Our management team is exceptional.Our mission is noteworthy.Indeed,in my new position,I have reemphasized our core mission:to reduce the harm caused by smoking.In pursuit of this important goal,we intend to help

6、 millions of consumers who will use our products and,at the same time,provide substantial value to our shareholders.22nd Century is in the rare position of having a virtual monopoly around the nicotine biosynthetic pathway in the tobacco plant.To capitalize on this extraordinary asset we have articu